Raltegravir-d4

A neuropeptide with diverse biological activities

此产品仅用于科学研究，我们不为任何个人用途提供产品和服务

库存: 现货

可选规格

包装

价格

促销价

数量
1mg

￥6662.00

5330.00

- +

已选 0 种 0 瓶

金额: ￥0.00

首页收藏

Background

Raltegravir-d₄ is intended for use as an internal standard for the quantification of raltegravir by GC- or LC-MS. Raltegravir is an orally bioavailable inhibitor of HIV-1 integrase (IC₅₀ = 15 nM in a strand transfer assay).¹ It inhibits the spread of HIV-1IIIb infection in MT-4 cell culture with 95% cell culture inhibitory concentration (CIC₉₅) values of 19 and 31 nM in medium containing 10% heat-inactivated fetal bovine serum (FBS) or 50% normal human serum, respectively. Formulations containing raltegravir have been used in combination therapy in the treatment of HIV-1 infection.

1.Summa, V., Petrocchi, A., Bonelli, F., et al.Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infectionJ. Med Chem.1(18)5843-5855(2008)